Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study-Reference-Cited by-同舟云学术

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study

Published:2011-12 Issue:12 Volume:19 Page:1405-1412
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

Nagashima H.,Suzuki M.,Araki S.,Yamabe T.,Muto C.

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology

Reference22 articles.

1. Association of radiographic and symptomatic knee osteoarthritis with health-related quality of life in a population-based cohort study in Japan: the ROAD study;Muraki;Osteoarthritis Cartilage,2010

2. Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study;Yoshimura;J Bone Miner Metab,2009

3. Double-blind study of Naproxen in osteoarthritis of the knee joint;Tanaka;J Rheumatol,1976

4. Naproxen in osteoarthrosis. Double-blind crossover trial;Blechman;Ann Rheum Dis,1978

5. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials;Bjordal;BMJ,2004

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different Dosage Regimens of Tanezumab for the Treatment of Chronic Low Back Pain: A Meta-analysis of Randomized Controlled Trials;Clinical Neuropharmacology;2022-12-22

2. Biological Therapy for Osteoarthritis, Efficacy and Safety: Focus on Monoclonal Antibodies against Nerve Growth Factor and Fibroblast Growth Factor-18;Open Access Macedonian Journal of Medical Sciences;2022-09-10

3. Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies;Pain and Therapy;2022-05-10

4. Efficacy and Safety of Anti–Nerve Growth Factor Antibody Therapy for Hip and Knee Osteoarthritis: A Meta-analysis;Orthopaedic Journal of Sports Medicine;2022-04-01

5. The Neuroimmune Interplay in Joint Pain: The Role of Macrophages;Frontiers in Immunology;2022-03-10